This is a study to evaluate the level of pain control and safety of different doses of a new extended-release pain med (CG5503) in people with moderate-to-severe chronic lower back pain. The new med will be compared to both oxycodone CR and a placebo. This international study is currently recruiting patients.
Read moreOne of the major risks of having spine surgery is the development of an infection. Discitis is an uncommon infection of the spinal disc... Read more »
Time for school, spine school. Millions of people experience some type of back pain every year. Billions of precious dollars are spent... Read more »
Medications are the most frequently recommended treatment for low back pain. Research has shown that 80% of primary care patients with... Read more »
Many would argue that back pain is inevitable and for some it becomes a sudden reality. Bending over to pick up a piece of paper, moving... Read more »
Spondylolisthesis (spaun-di-lo-lie-thee-sis) is a mouthful and is a common cause of low back pain (although it can exist anywhere in the... Read more »
Australian researchers say even very severe back pain is unlikely to mean the sufferer has a more serious health issue such as a broken vertebrae or... Read more »
This is a study to determine the safety and effectiveness of extended-release Vicodin (hydrocodone and acetaminophen) in patients with moderate to... Read more »
This is a study to determine the safety and effectiveness of a new transdermal pain med in patients with chronic lower back pain. This national study... Read more »
Source: ADAM Encyclopedia
and CausesThe origin of the pain is often unknown, and imaging studies may fail to determine its cause. Disk disease, spinal arthritis, and muscle... Read more »
According to a new study, practicing yoga may help decrease lower back pain. Read more »